Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: A clinicopathologic analysis of 61 patients

• Main Authors: Loghavi, S, Alayed, K, Aladily, T.N, Zuo, Z, Ng, S.-B, Tang, G, Hu, S, Yin, C.C, Miranda, R.N, Medeiros, L.J, Khoury, J.D
• Other Authors: PATHOLOGY
• Format: Article
• Published: 2020
• Subjects: cyclophosphamide; dexamethasone; doxorubicin; etoposide; prednisone; vincristine; antineoplastic agent; abdominal pain; adult; age distribution; aged; Article; cancer chemotherapy; cancer prognosis; cancer staging; cancer survival; carcinogenesis; clinical evaluation; cohort analysis; colorimetry; controlled study; correlational study; cytogenetics; diarrhea; epistaxis; Epstein Barr virus; Epstein Barr virus infection; event free survival; female; fluorescence in situ hybridization; follow up; gastrointestinal symptom; gene overexpression; gene rearrangement; health impact assessment; histopathology; human; Human immunodeficiency virus infection; human tissue; immunocompromised patient; immunophenotyping; major clinical study; male; nose ulcer; oncogene myc; outcome assessment; overall survival; plasmablastic lymphoma; rectum hemorrhage; rhinorrhea; sinusitis; very elderly; virus detection; age; complication; genetics; middle aged; pathology; treatment outcome; young adult; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Epstein-Barr Virus Infections; Female; Humans; Male; Middle Aged; Neoplasm Staging; Plasmablastic Lymphoma; Treatment Outcome; Young Adult
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/180909
• Institution: National University of Singapore

10.1186/s13045-015-0163-z